Assertio Therapeutics Inc (ASRT) — Capital Reinvestment Ratio
Latest as of December 2023:
0.03x
Assertio Therapeutics Inc (ASRT) has a Capital Reinvestment Ratio of 0.03x as of December 2023, meaning it reinvests 0% of its operating cash flow ($5.71 Million) in capital expenditures ($180.00K). See Assertio Therapeutics Inc (ASRT) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.03x
Capex / Operating Cash Flow
Operating Cash Flow
$5.71 Million
USD
Capital Expenditures
$180.00K
USD
Data as of
Dec 2023
Most recent filing
Assertio Therapeutics Inc Capital Reinvestment Ratio (2005–2023)
This chart tracks Assertio Therapeutics Inc's Capital Reinvestment Ratio across 14 annual periods.
Annual Capital Reinvestment Ratio for Assertio Therapeutics Inc (2005–2023)
Year-by-year Capital Reinvestment Ratio for Assertio Therapeutics Inc from 2005 to 2023. For live market cap and broader valuation context, see market value of Assertio Therapeutics Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.01x | $49.60 Million | $628.00K | ▲ +263.2% |
| 2022 | 0.00x | $78.60 Million | $274.00K | ▼ -63.7% |
| 2021 | 0.01x | $5.52 Million | $53.00K | ▼ -41.4% |
| 2019 | 0.02x | $90.47 Million | $1.48 Million | ▼ -78.5% |
| 2018 | 0.08x | $72.50 Million | $5.51 Million | ▲ +609.1% |
| 2017 | 0.01x | $62.17 Million | $666.00K | ▼ -75.5% |
| 2016 | 0.04x | $65.50 Million | $2.86 Million | ▼ -76.5% |
| 2015 | 0.19x | $143.89 Million | $26.71 Million | ▼ -7.7% |
| 2013 | 0.20x | $9.75 Million | $1.96 Million | ▲ +1561.4% |
| 2011 | 0.01x | $57.65 Million | $698.00K | ▼ -96.5% |
| 2009 | 0.34x | $1.84 Million | $629.00K | ▲ +346.2% |
| 2008 | 0.08x | $3.35 Million | $257.00K | ▲ +620.8% |
| 2007 | 0.01x | $14.66 Million | $156.00K | ▼ -61.2% |
| 2005 | 0.03x | $28.82 Million | $791.25K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow